DLPIC
EVH icon

Davide Leone & Partners Investment Company’s Evolent Health EVH Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-53,734
Closed -$1.14M – 47
2021
Q2 		$1.14M Sell
53,734
-102,389
-66% -$2.05M 0.05% 52
2021
Q1 		$3.15M Buy
156,123
+44,453
+40% +$845K 0.39% 22
2020
Q4 		$1.79M Buy
+111,670
New +$1.48M 0.19% 37

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Davide Leone & Partners Investment Company's EVH Position: Q3 2021 in Review

Davide Leone & Partners Investment Company sold out of Evolent Health (EVH) in Q3 2021, closing a stake of 53,734 shares — an estimated $1.14M sold.

Davide Leone & Partners Investment Company first reported a position in EVH in Q4 2020 and held it in 3 quarters. The position peaked at $3.15M in Q1 2021. 209 funds tracked by Wall St. Rank hold EVH as of Q3 2021.

  • Davide Leone & Partners Investment Company reported no remaining Evolent Health position as of Q3 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 53,734 Evolent Health shares in Q3 2021, an estimated $1.14M.
  • Davide Leone & Partners Investment Company first reported a position in Evolent Health in Q4 2020 and held it in 3 quarters.
  • Davide Leone & Partners Investment Company's Evolent Health position peaked at $3.15M in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Evolent Health as of Q3 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q3 2021, filed 15 Nov 2021.